Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route
Clinical trial NCT05125627 · COMPLETED
Trial details
- NCT number
- NCT05125627
- Sponsor
- Joint Stock Company "Farmak"
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-28
- Primary completion
- 2019-10-21
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.